Transforming Brain Health
The Mindstrong Health Mission:
Better Outcomes Through Measurement-Based Care
Our Formidable Challenge: Transforming Healthcare
In this decade, neuropsychiatric disorders represent the largest source of medical disability for people under age 50. The costs are among the highest of all medical disorders, in part because mental disorders begin early and can result in many years lost to disability. For people in the second half of life, neurodegenerative disorders are becoming increasingly prevalent, with dementia affecting one in three over age 80. Our best hope for improving outcomes for people with neurodevelopmental and neurodegenerative disorders is early prediction and preemptive interventions.
High costs, poor outcomes, and late detection are driven, in part, by a lack of valid, objective measurement where and when it matters most — in a person’s day-to-day environment. Progress depends on having better data through rigorous, real-world measurement.
How to Transform Healthcare
Clinical researchers rely on episodic, subjective assessments of symptoms that do not translate well to day-to-day function. Current assessments not only lack precision for measuring outcomes, they lack precision for diagnosis, resulting in trials that mix people with similar symptoms but potentially different disorders. This “diagnostic heterogeneity” is an inescapable challenge for testing new treatments in neuropsychiatric disorders.
Neuropsychiatric care is one of the few areas of medicine that does not measure progress with objective tools. We don’t manage what we don’t measure. Research has shown that mental health clinicians fail to detect worsening in 4 of 5 patients who experience increased symptom severity. National policy experts have declared that measurement-based care is an urgent priority for improving mental health outcomes. (Fortney et al., 2016)
Better Outcomes Across Every Population
Our lack of detection leads to egregious delays in treatment. A recent U.S. study reported a duration of untreated psychosis of 74 weeks. (Addington et al, 2015) Poor outcomes can be attributed to the delay in getting care and care that is reactive, not proactive.
Preempting Disease and Intercepting Relapse
It is going to take more than a measurement-based approach to transform healthcare. Measurement is our foundation for a new platform of interventions that will ensure better outcomes, with a goal of intercepting illness at an early stage and recovery at a later stage.
The Learning Healthcare System
At Mindstrong we believe in data, not only because we need better measures of outcome and more precise diagnoses, but also because we need a healthcare system that learns from each interaction.